UPADACITINIB (RINVOQ®)
Clinical Indication
Rheumatoid arthritis
Comments
In line with NICE TA665
Date of classification
February 2020
Review date
March 2021
Red
Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).